Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EM4965 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Bell's palsy, Hypoaesthesia, Swollen tongue, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: ARIPIPRAZOLE; MONTELUKAST
Current Illness: Asthma
Preexisting Conditions: Medical History/Concurrent Conditions: Bipolar disorder; Lactation decreased; Sciatica
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC 'Split Type': GBPFIZER INC2021708388
Write-up: atypical palsy; facial numbness; numbness facial; This is a spontaneous report from a contactable consumer received from the Regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106130734234670-CMRTH, Safety Report Unique Identifier GB-MHRA-ADR 25466922. A 44-year-old female patient (non pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EM4965) via an unspecified route of administration on 01May2021 as 2nd dose, single dose for covid-19 immunization. Medical history included suppressed lactation, sciatica, asthma, bipolar disorder. Patient had no symptoms associated with COVID-19. Patient was not enrolled in clinical trial. The patient was not breastfeeding at the time of reporting. Concomitant medication included aripiprazole taken for bipolar disorder, start and stop date were not reported, montelukast taken for asthma, start and stop date were not reported. The patient previously received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER1741), via unspecified route of administration on 27Feb2021 as 1st dose, single dose for covid-19 immunization for the reaction sciatica. The patient experienced atypical palsy and facial numbness on an unspecified date. Facial numbness had started some weeks after second dose. Atypical palsy, cranial nerves test was ok. Nurse practitioner advised the patient to report here. The patient also experienced numbness facial on 04Jun2021. The patient had also registered that sciatica which was started sometime after first dose (atypical, numb but no pain). Patient had not tested positive for COVID-19 since having the vaccine. The patient underwent lab tests and procedures which included COVID-19 virus test (SARS-CoV-2 test): result negative on an unspecified date (No - Negative COVID-19 test). The outcome of events palsy and facial numbness was recovering, and numbness facial was not recovered. No follow up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166